D35.7
Benign neoplasm of other specified endocrine glands
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign neoplasm of the endocrine glands refers to a non-cancerous growth that develops in glands responsible for hormone production. These growths are generally not aggressive and do not spread to other parts of the body. The specific ICD-10 code D35.7 is used to identify benign tumors that originate in endocrine glands not categorized under other specific codes. Since endocrine glands play a vital role in regulating various bodily functions through hormone secretion, any growth in these areas can potentially impact overall health depending on the gland involved.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose individuals to glandular growths Hormonal imbalances which may promote abnormal cell growth in endocrine tissues Environmental exposures, including radiation or certain chemicals Pre-existing endocrine disorders or conditions that affect cell growth control Age-related changes in cell regulation and regenerative processes
Key Symptoms: Often asymptomatic and discovered incidentally during examinations or imaging tests Palpable lumps or swelling in the affected area Hormonal symptoms depending on the gland involved, such as unusual weight gain or loss, changes in energy levels, or mood swings Localized discomfort or pain if the tumor grows large enough to exert pressure on surrounding tissues Symptoms of hormone imbalance, such as abnormal blood sugar levels, blood pressure fluctuations, or fatigue
Diagnostic & Treatment
Diagnosis Path: The diagnosis of a benign neoplasm of the endocrine glands typically involves a combination of imaging studies and laboratory tests. Techniques include ultrasound, CT scans, or MRI to locate and evaluate the size and characteristics of the tumor. Blood tests may assess hormone levels to determine functional activity of the affected gland. In some cases, a biopsy might be performed to confirm the benign nature of the growth. Medical history and physical examination are integral components for assessing the overall health and detecting any signs of hormonal imbalance.
Treatment Protocols: Treatment options depend on the size, location, and activity of the tumor, as well as the presence of symptoms. Options may include:
Clinical Advice & FAQs
Billing Guidance
Is D35.7 a billable ICD-10 code?
Yes, D35.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D35.7?
Clinical documentation must specify the nature of Benign neoplasm of other specified endocrine glands and any associated comorbidities for accurate reporting.
Cite this Clinical Reference